Haoxiangni Health Food (002582) Fundamentals 2026 — P/E 2.1x, Revenue Analysis | SniperIQ
Haoxiangni Health Food (002582) is a CN-listed Consumer Defensive company in Packaged Foods with a market capitalization of ¥4.2B, trading at ¥9.37 on the SHZ. This SniperIQ fundamentals page covers Haoxiangni Health Food's valuation (P/E 2.1x, P/B 0.8x), profitability (net margin 136.4%), revenue (¥1.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Haoxiangni Health Food's market cap?
Haoxiangni Health Food (002582) has a market capitalization of approximately ¥4.2B, trading at ¥9.37 on the SHZ. Market cap moves with the live share price.
What is Haoxiangni Health Food's P/E ratio?
Haoxiangni Health Food's trailing twelve-month P/E ratio is 2.1x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Haoxiangni Health Food?
Haoxiangni Health Food runs a net profit margin of 136.4%, a gross margin of 30.3%, and an operating margin of 181.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Haoxiangni Health Food generate?
Haoxiangni Health Food reported revenue of ¥1.3B for fiscal year 2025, with net income of ¥866M and earnings per share (EPS) of 2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Haoxiangni Health Food pay a dividend?
Haoxiangni Health Food offers a trailing dividend yield of about 6.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Haoxiangni Health Food financially healthy?
Haoxiangni Health Food carries a debt-to-equity ratio of 0.13x and a current ratio of 1.54x, with a market beta of 0.42. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Haoxiangni Health Food a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Haoxiangni Health Food (002582) the key facts are: market cap ¥4.2B, P/E 2.1x, revenue ¥1.3B, 52-week range 8.32-16.57. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Haoxiangni Health Food's full fundamentals live
Get Haoxiangni Health Food's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.